EMILY COOPER: Open Payments
NPI 1336667021 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,565 in 111 payments from 20 companies in 2025. Trend: 2023 $188 · 2024 $1,790 · 2025 $2,565
Food & beverage: $2,461Education: $89Consulting: $15
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 28 | $668 |
| Regeneron Healthcare Solutions, Inc. | 14 | $396 |
| GENZYME CORPORATION | 7 | $254 |
| CSL Behring | 8 | $188 |
| Novartis Pharmaceuticals Corporation | 8 | $182 |
| GlaxoSmithKline, LLC. | 7 | $149 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $144 |
| Amgen Inc. | 12 | $135 |
| Ionis Pharmaceuticals, Inc. | 3 | $83 |
| Lilly USA, LLC | 3 | $72 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, NEFFY, AIRSUPRA, Rhapsido, NUCALA, Hizentra.
Industry payments across MD — which companies pay providers there.
